The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

Psoriasis and dandruff can both trigger itching and flaky scalp skin. Psoriasis is a chronic autoimmune disorder that can cause thick patches of skin known as plaques on the scalp to become dry ...

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

For scalp psoriasis or seborrheic dermatitis, a dermatologist typically recommends using a salicylic acid shampoo 2 to 3 ...

It can also develop on other parts of your body, like your scalp or knees. It’s thought that about 3% of the population has psoriasis. Kids and teens can get psoriasis, but it happens mainly in ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...

No matter the task, we're tracking every last dollar from start to finish. Up next: treating scalp psoriasis. It was only after she visited a dermatologist for treatment that she started to see ...